The 8th annual World Orphan Drug Congress is the marketplace for orphan drug professionals looking at the complete value chain of orphan drug development, from clinical development and R&D to corporate development and market access.
Being Europe’s largest Orphan Drug Congress, this event will provide a platform for you to showcase your thought leadership and expertise pharma, biotechs, payers, regulators and patient advocates.
We thank our Advisory Board members for their contribution to the agenda this year:
Vice President and Head of Gene Therapy Development
Prof Michael Linden
VP Gene Therapy & Head, GMI
Yann Le Cam
Chief Executive Officer
Dr Bruno Sepodes
Chair of COMP
Genetic Alliance UK
Founder & CEO
Dr Carlo Incerti
SVP, Head of Global Medical Affairs, CMO
Genzyme, A Sanofi Company
The Conference offers strategic keynote plenaries, themed tracks and dedicated networking sessions, you have the chance to really tailor the event to the needs of your day-to-day role.
The Exhibitors have a unique opportunity to put their business products and services in front of potential buyers looking to source the latest technologies in the orphan drugs industry.
The pre-congress workshops will offer insights into Pricing, Reimbursement and Market Access Challenges and Accelerating Commercialization of Rare Disease Treatments in the afternoon.
Meet and listen to biotech start-ups and investors in our Pitch & Partner track where the most promising companies showcase their orphan drug technology and pipeline.
Enjoy discussions on: